IRIS Accounts Production v25.3.0.601 10083748 director 1.4.23 31.3.24 31.3.24 20.10.25 false true false false true false Auditors Opinion iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 10083748 2023-03-31 10083748 2024-03-31 10083748 2023-04-01 2024-03-31 10083748 2022-03-31 10083748 2022-04-01 2023-03-31 10083748 2023-03-31 10083748 ns15:EnglandWales 2023-04-01 2024-03-31 10083748 ns14:PoundSterling 2023-04-01 2024-03-31 10083748 ns10:Director1 2023-04-01 2024-03-31 10083748 ns10:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10083748 ns10:SmallEntities 2023-04-01 2024-03-31 10083748 ns10:Audited 2023-04-01 2024-03-31 10083748 ns10:SmallCompaniesRegimeForDirectorsReport 2023-04-01 2024-03-31 10083748 ns10:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10083748 ns10:FullAccounts 2023-04-01 2024-03-31 10083748 ns10:RegisteredOffice 2023-04-01 2024-03-31 10083748 ns5:CurrentFinancialInstruments 2024-03-31 10083748 ns5:CurrentFinancialInstruments 2023-03-31 10083748 ns5:ShareCapital 2024-03-31 10083748 ns5:ShareCapital 2023-03-31 10083748 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 10083748 ns5:RetainedEarningsAccumulatedLosses 2023-03-31 10083748 ns5:PlantMachinery 2023-03-31 10083748 ns5:PlantMachinery 2023-04-01 2024-03-31 10083748 ns5:PlantMachinery 2024-03-31 10083748 ns5:PlantMachinery 2023-03-31 10083748 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-03-31 10083748 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2023-03-31

REGISTERED NUMBER: 10083748 (England and Wales)

LONDON HEART CLINIC LIMITED

Financial Statements for the Year Ended 31 March 2024

| LONDON HEART CLINIC LIMITED (Registered number: 10083748) |

Contents of the Financial Statements

for the Year Ended 31 March 2024

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 3 |

| LONDON HEART CLINIC LIMITED |

Company Information

for the Year Ended 31 March 2024

| DIRECTOR: | Jaspal Singh Kooner

| REGISTERED OFFICE: | Unit 1 Manhattan Business Park, Westgate

| Ealing, London, W5 1UP

| W5 1UP

| REGISTERED NUMBER: | 10083748 (England and Wales)

| AUDITORS: | DSJ Partners (UK) Limited

| 2nd Floor

| 1 Bell Street

| London

| NW1 5BY

| LONDON HEART CLINIC LIMITED (Registered number: 10083748) |

Balance Sheet

31 March 2024

| 2024 |  | 2023

| Notes | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 39,813 |  | 21,253 |  |

CURRENT ASSETS

Debtors | 5 | 1,253,719 |  | 1,156,041 |  |

Cash in hand | 414,691 |  | 570,189 |  |

1,668,410 |  | 1,726,230 |  |

CREDITORS

Amounts falling due within one year | 6 | (160,850 | ) | (147,118 | ) |

NET CURRENT ASSETS | 1,507,560 |  | 1,579,112 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 1,547,373 |  | 1,600,365 |  |

CAPITAL AND RESERVES

Called up share capital | 1,000 |  | 1,000 |  |

Retained earnings | 1,546,373 |  | 1,599,365 |  |

1,547,373 |  | 1,600,365 |  |

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 October 2025 and were signed by:

Jaspal Singh Kooner - Director

| LONDON HEART CLINIC LIMITED (Registered number: 10083748) |

Notes to the Financial Statements

for the Year Ended 31 March 2024

1. | STATUTORY INFORMATION

| LONDON HEART CLINIC LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Going concern

| The financial statements have been prepared on a going concern basis as the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and will be able to pay its debts as and when they fall due.

| In order to assess the going concern assumption, the company has prepared and considered trading and cashflow forecasts for the period covering at least 12 months from the date of approval of these financial statements.

| Having considered the information available to her to the date of signing the financial statements, the director is satisfied that the company remains a going concern.

| Revenue

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Depreciation is provided on the following basis:

| Fixtures and fittings - 25% straight-line method

| Computer equipment - 25% straight-line method

| The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

| Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

| Fixed assets impairment

| Fixed assets are reviewed for impairment if events or changes in circumstances indicate that the carrying amount may not be recoverable or as otherwise required by relevant accounting standards.

| Shortfalls between the carrying value of fixed assets and their recoverable amounts, being the higher of net realisable value and value in use, are recognised as impairments. All other impairment losses are recognised in the profit and loss account.

| LONDON HEART CLINIC LIMITED (Registered number: 10083748) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2024

2. | ACCOUNTING POLICIES - continued

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Pension

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| LONDON HEART CLINIC LIMITED (Registered number: 10083748) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2024

2. | ACCOUNTING POLICIES - continued

| Financial instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102, in full, to all of its financial instruments.

| Financial assets and financial liabilities are recognised when the company becomes a party to the contractual provisions of the instrument, and are offset only when the company currently has a legally enforceable right to set off the recognised amounts and intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

| Financial assets

| Trade debtors

| Trade debtors which are receivable within one year and which do not constitute a financing transaction are initially measured at the transaction price. Trade debtors are subsequently measured at amortised cost, being the transaction price less any amounts settled and any impairment losses.

| Where the arrangement with a trade debtor constitutes a financing transaction, the debtor is initially and subsequently measured at the present value of future payments discounted at a market rate of interest for a similar debt instrument.

| A provision for impairment of trade debtors is established when there is objective evidence that the amounts due will not be collected according to the original terms of the contract. Impairment losses are recognised in profit or loss for the excess of the carrying value of the trade debtor over the present value of the future cash flows discounted using the original effective interest rate. Subsequent reversals of an impairment loss that objectively relate to an event occurring after the impairment loss was recognised, are recognised immediately in profit or loss.

| Financial liabilities and equity

| Financial instruments are classified as liabilities and equity instruments according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

| Equity instruments

| Financial instruments classified as equity instruments are recorded at the fair value of the cash or other resources received or receivable, net of direct costs of issuing the equity instruments.

| Trade creditors

| Trade creditors payable within one year that do not constitute a financing transaction are initially measured at the transaction price and subsequently measured at amortised cost, being the transaction price less any amounts settled.

| Where the arrangement with a trade creditor constitutes a financing transaction, the creditor is initially and subsequently measured at the present value of future payments discounted at a market rate of interest for a similar instrument.

| Derecognition of financial assets and liabilities

| A financial asset is derecognised only when the contractual rights to cash flows expire or are settled, or substantially all the risks and rewards of ownership are transferred to another party, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party. A financial liability (or part thereof) is derecognised when the obligation specified in the contract is discharged, cancelled or expires.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 10 (2023 - 9 ) .

| LONDON HEART CLINIC LIMITED (Registered number: 10083748) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2024

4. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 April 2023 | 53,335 |  |

| Additions | 42,267 |  |

| At 31 March 2024 | 95,602 |  |

| DEPRECIATION

| At 1 April 2023 | 32,082 |  |

| Charge for year | 23,707 |  |

| At 31 March 2024 | 55,789 |  |

| NET BOOK VALUE

| At 31 March 2024 | 39,813 |  |

| At 31 March 2023 | 21,253 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2024 | 2023 |

£ | £ |

| Trade debtors | 383,393 |  | 399,907 |  |

| Amounts owed by group undertakings | 856,965 |  | 741,084 |  |

| Other debtors | 13,361 |  | 15,050 |  |

1,253,719 |  | 1,156,041 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2024 | 2023 |

£ | £ |

| Trade creditors | 96,298 |  | 38,939 |  |

| Taxation and social security | 31,888 |  | 5,988 |  |

| Other creditors | 32,664 |  | 102,191 |  |

160,850 |  | 147,118 |  |

7. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

| The Report of the Auditors was unqualified.

| Bharat Kumar Dhanani (Senior Statutory Auditor)

| for and on behalf of DSJ Partners (UK) Limited

| LONDON HEART CLINIC LIMITED (Registered number: 10083748) |

Notes to the Financial Statements - continued

for the Year Ended 31 March 2024

8. | RELATED PARTY DISCLOSURES

| Director, Mr J S Kooner has provided working capital loan to the company. This loan is interest free and repayable on demand. At the year end, balance owed to him was £2,635 (2023: £Nil).

| The company has provided working capital loan to a fellow group company, Imperial Bio-Discovery Ltd. At the year end, amount receivable from them was £292,156 (2023: £246,110). The loan is non-interest bearing and repayable on demand.

| The company has provided working capital loan to a fellow group company, Ealing Paces MRCP Limited. At the year end, amount receivable from them was £111,979 (2023: £100,785). The loan is non-interest bearing and repayable on demand.

| The company has provided working capital loan to a fellow group company, Golden Manor Healthcare (Ealing) Limited. At the year end, amount receivable from them was £428,985 (2023: £389,340). The loan is non-interest bearing and repayable on demand.

| The company has provided working capital loan from a fellow group company, JSK Private Practice Ltd. At the year end, amount receivable from them was £23,845 (2023: £720). The loan is non-interest bearing and repayable on demand.

9. | ULTIMATE CONTROLLING PARTY

| The immediate parent company is 57 AG Limited which is registered in England and Wales and for which group financial statements are prepared. These are the smallest and largest group for which consolidated accounts including Golden Manor Healthcare (Ealing) Limited are prepared. Copies of the group financial statements are available from Companies House, Crown Way, Maindy, Cardiff, CF1 43UZ .

| The company is under the control of Professor Jaspal Singh Kooner.